Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Carcinoma 1

Interventions

pembrolizumab 4anlotinib 4sintilimab 3Paclitaxel 3Leucovorin 3Cetuximab 3niraparib 2Sorafenib 2Radiotherapy 2Nivolumab 2Hyperthermic Intraperitoneal Chemotherapy 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Docetaxel 2Cisplatin 2vistusertib 1titanium silicide 1tislelizumab 1tirbanibulin 1surufatinib 1regorafenib 1pemigatinib 1olaparib 1elemene 1durvalumab 1donafenib 1daromun 1avelumab 1aumolertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma × Escitalopram × Clear all
NCT00935675 2009-09-02

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
100 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡